Return to study ST003131 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
1,2-dilinolenoyl-galactosylglycerol (18:3/18:3)* ME820061 MGDG 18:3/0:0/18:3 2046-Reversed phase POSITIVE ION MODE
1-linoleoyl-2-linolenoyl-digalactosylglycerol (18:... ME820080 DGDG 18:2_18:3 2073-Reversed phase POSITIVE ION MODE
1-linoleoyl-2-linolenoyl-galactosylglycerol (18:2/... ME820081 MGDG 18:2_18:3 2209-Reversed phase POSITIVE ION MODE
1-palmitoyl-2-linolenoyl-digalactosylglycerol (16:... ME820094 DGDG 16:0_18:3 2278-Reversed phase POSITIVE ION MODE
1-palmitoyl-2-linolenoyl-galactosylglycerol (16:0/... ME820095 MGDG 16:0_18:3 2455-Reversed phase POSITIVE ION MODE
1-palmitoyl-2-linoleoyl-digalactosylglycerol (16:0... ME820096 DGDG 16:0_18:2 2498-Reversed phase POSITIVE ION MODE
1-palmitoyl-2-linoleoyl-galactosylglycerol (16:0/1... ME820097 MGDG 16:0_18:2 2731-Reversed phase POSITIVE ION MODE


  logo